Navigation Links
Phosphagenics' A$19.3 million Capital Raising
Date:7/11/2014

MELBOURNE, Australia, July 11, 2014 /PRNewswire/ -- Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), today announced that it has raised A$19.3 million via a placement of A$16.3 million to institutional investors in Europe, the U.S., Asia and Australia and A$3 million from a share purchase plan (SPP) to be offered to existing shareholders.  The placement of A$16.3 million will be made in two tranches.

"This capital raising positions us strongly to fulfil our commercialisation objectives and fully funds our scheduled TPM®/opioid clinical trial programs.  The capital raised is earmarked for our pivotal TPM®/Oxymorphone Phase 2 clinical trial in the USA scheduled for the first half of 2015 and our upcoming TPM®/Oxycodone Phase 2 trial in Australia," said CEO, Harry Rosen.

"The capital raising comes at a time when the Company is focusing on exploiting the commercialization of several of its lead programs.  We have recently strengthened our business development capacity in the U.S. to assist in this process.  While we have unquestionably shown that our technology provides enhanced delivery solutions across a wide range of products, we now need to translate this to commercial outcomes," said Harry Rosen.

The completion of this capital raising and the investment by new and existing institutional shareholders is a strong endorsement of the TPM® technology and commercial prospects of Phosphagenics.

The institutional placement is for initially 153,000,000 shares at 8 cents per share. This represents a discount of 11% to the last sale price of 9 cents.  A placement of a further 51,000,000 shares at the same pric
'/>"/>

SOURCE Phosphagenics Limited
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phosphagenics Appoints Neura Therapeutik as US Strategic Commercial Advisors
2. Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million
3. University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services
4. Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering
5. 2013 Was a Multimillion-Dollar Year for The Trendlines Group
6. Isis Pharmaceuticals to Receive $7.5 Million from Alnylam
7. Sanomedics Secures $5 Million Revolving Credit Facility With TCA Global Credit Master Fund, LP To Fund Growth And Future Acquisitions
8. Forus Health Raises Rs 50 Crore ($8.2 Million) in Series B Funding Led by Asian Healthcare Fund
9. Adamas Pharmaceuticals Earns $40 Million in Milestone Payments from Forest Laboratories for MDX-8704
10. Oxford Finance Closes $25 Million Senior Credit Facility with Entellus Medical
11. Auspex Raises $35 Million And Appoints Industry Veteran Gerald Proehl To Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... YORK , July 30, 2014 ACCESS ... for oncology supportive care, announced that its novel product ... in an article on OncLive.com titled, "Study Finds Mouth ... Cancers."  Dr. Steve Sonis , a leading expert ... seen in the oncology community for evidence-based strategies for ...
(Date:7/30/2014)... , July 30, 2014   Bluegrass ... focused on innovating lifesaving devices and methods for ... million in Series A financing, which was led ... from the deal will allow Bluegrass Vascular to ... Catheter System, enhance manufacturing capabilities, and proceed with ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds 2
... Dilon expands its portfolio of breast imaging solutions ... Mammography Information System technology by KLAS for three ... loyalty are the foundation of PenRad,s success. Together ... and an information management system that significantly improves ...
... Hurricane Irene came rushing up the East Coast as a ... United States, many states in the Northeast began to worry. The ... hurricanes. Coastal towns from New Jersey all the way up to ... City was one that took steps that had not been seen ...
Cached Medicine Technology:Dilon Diagnostics® Partners With PenRad® 2Dilon Diagnostics® Partners With PenRad® 3Hospitals Evacuated in Preparation for Hurricane Irene with Aid of Pulse Oximeter 2
(Date:7/30/2014)... July 30, 2014 Hamilton Facial ... of its new Carmel office on July 30th. After ... finally be moving to the state-of-the-art suite, located only ... innovative space will allow for one-on-one patient comfort, shorter ... experience. , Dr. Hamilton’s new office-suite will continue ...
(Date:7/30/2014)... DRE Medical — a leading medical ... of its Medical Trade Shows & Conventions Calendar ... and equipment vendors. , The calendar is a continually-updating ... United States and around the world. Hundreds of entries ... is always growing. , Information listed on each trade ...
(Date:7/30/2014)... The Technology Association of Georgia in collaboration with ... issued its final call for applications and nominations for ... until August 29th 2014 to be considered for this ... the Excalibur Judging Committee. Companies selected as semi-finalists will ... interviewing process. , The TAG Excalibur Awards recognize ...
(Date:7/30/2014)... LTC Consumer, an independent, free online service to help ... Instant Quote tool on its website, LTCconsumer.com , announced ... are free and unlimited. , The Instant Quote tool ... including age, gender, and state of residence – and delivers ... to enter any contact information to get started). There is ...
(Date:7/30/2014)... July 30, 2014 Children’s Hospital of ... Safety Day from 4 p.m. to 7 p.m. Wednesday, ... 7 Mile Road, Livonia, MI 48152). The event will ... helmets, children’s activities, music, snacks and local public safety ... the Children’s Hospital of Michigan Foundation. , The ...
Breaking Medicine News(10 mins):Health News:Hamilton Facial Plastic Surgery Opens New Carmel Office 2Health News:DRE Launches Online Interactive Medical Trade Show Calendar 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 3Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 3Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 4
... -- About 14 percent of strokes happen while people are ... to the hospital in time for a potentially brain-saving treatment, ... for ischemic stroke must be given within a few hours ... stroke symptoms often can,t receive the treatment since we can,t ...
... new to adolescents, researchers and physicians at Nationwide Children,s ... that is raising some concern among medical professionals. Often ... form of self-injurious behavior that involves inserting foreign objects ... into muscle. A recent study, published in the June ...
... prevalence of overall cardiovascular risk in the Spanish working population ... (8% on men and 2% in women). This prevalence increases ... farming sector, followed by construction, industry and services. "In ... of cardiovascular risk, but only a minority of these people ...
... ROCHESTER, Minn. - Constipation is definitely not a glamorous ... and costs more than $1 billion annually to evaluate ... bloating, discomfort, and straining associated with constipation lead sufferers ... researchers recently had success in the clinical trial of ...
... By Steven Reinberg HealthDay Reporter , MONDAY, May ... associated with a lethal nervous system disease known as amyotrophic ... explain, however, that this does not mean people with long ... they are at higher risk for it. "We have ...
... of U.S. veterans ages 70 and older finds that the ... methods. However, for many less healthy veterans the burdens of ... we really need to target screening in older adults, so ... while those who won,t benefit aren,t exposed to unnecessary burdens," ...
Cached Medicine News:Health News:Research Suggests 1 in 7 Strokes Happens During Sleep 2Health News:A new study on self-injury behavior encourages quick and targeted intervention 2Health News:6 percent of Spanish workers have high cardiovascular risk 2Health News:Mayo Clinic researchers find new treatment for constipation 2Health News:Ring Finger Length Linked to ALS, Study Suggests 2Health News:Ring Finger Length Linked to ALS, Study Suggests 3Health News:Blood test for colon cancer screening beneficial for some seniors, but not for many others 2
... premium product for acne, XtremeClear, powered ... on a scalable multi-application platform. A ... acne, XtremeClear works fast, providing noticeable ... treatments. Uncompromising safety in each of ...
... SpaTouch was designed specifically to meet the varying ... is a simple to use, compact, dual application ... lucrative field of light based hair removal. SpaTouch ... is safe for use on nearly all face ...
... all of the benefits and functionality ... the additional feature of being able ... scanner for importing and storage of ... images. This additional feature allows for ...
Inquire...
Medicine Products: